Details

Risk Classification of Good Pharmacovigilance Practices (GVP) Observations (GUI-0063) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 3, 2026 · edition #6
Timestamp: 2026-03-03T06:08:39.359Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-pharmacovigilance-observations-0063.html
Replay URL: https://replay.healtharchive.ca/job-6/20260303060839/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-pharmacovigilance-observations-0063.html#ha_snapshot=617364
ID: 617364
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots